Switzerland opens a door by allowing non-EU catalogue varietals to be grown
24th November 2020
CBD in Switzerland
The Swiss market is different to many other markets, not simply due to its higher 1% THC limit in comparison to others but also due to flexible regulations around cultivation. This page contains all of our content that relates to Switzerland, including all of our detailed regulatory and market reports, our business and regulatory briefings, and all of our up-to-date trackers, databases and live alerts.
Business briefing
Regulatory briefing
More Regulatory briefing Market reports
Top brands & pricing report: country comparison 2020 Q3
23rd November 2020
Regulatory reports
Regulatory report: medical and recreational cannabis – a global overview
9th November 2020
Market trackers
Switzerland price & product benchmarking dashboard Q3 2020
19th October 2020
Charts and infographics
Refined oil regional wholesale pricing
8th September 2020
Alerts roundup
CBD-Intel global alerts database February
4th February 2021
A more open and relaxed market in Switzerland
CBD is not a scheduled substance in Switzerland; its legality in the finished product depends on the intended use. Some peculiarities of the Swiss market make it noticeably different from other markets. The market can be considered more open in terms of availability of CBD products as regulations are very flexible and cultivation of hemp is not only permitted but products can also contain up to 1% of THC. Flowers are also widely available while other product categories that are popular in other markets are not as popular. This difference is probably related to the ease of production of the flowers and more traditional consumer preferences in the country.
Switzerland also plans to launch trials in 2021 as part of a move toward legalising cannabis with high THC. Municipalities will be able to submit relevant projects to the government for approval, with trials expected to start sometime in mid-2021.
